Edition:
United Kingdom

Akebia Therapeutics Inc (AKBA.OQ)

AKBA.OQ on NASDAQ Stock Exchange Global Market

15.23USD
23 Feb 2018
Change (% chg)

$0.20 (+1.33%)
Prev Close
$15.03
Open
$15.08
Day's High
$15.26
Day's Low
$14.78
Volume
110,974
Avg. Vol
129,716
52-wk High
$20.25
52-wk Low
$8.60

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 41.28 -0.493
Jun '17 28.52 -0.527
Mar '17 20.86 -1.149
FY 2016 Dec '16 1.53 -0.989
Sep '16 0.00 -0.958
Jun '16 0.00 -0.946
Mar '16 0.00 -0.700
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 4 41.56 54.00 28.00 --
Quarter Ending Jun-18 4 38.44 50.00 28.00 --
Year Ending Dec-18 9 167.16 220.00 122.00 91.52
Earnings (per share)
Quarter Ending Mar-18 4 -0.36 -0.01 -0.59 --
Quarter Ending Jun-18 4 -0.41 -0.25 -0.64 --
Year Ending Dec-18 9 -1.69 -0.53 -3.21 -2.11
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta 1.02 0.90 0.89
Price to Sales (TTM) 17.57 110.72 5.77
Price to Book (MRQ) 14.14 13.56 5.41
Price to Tangible Book (MRQ) 15.69 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 62.22 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 398.34 9.24
Sales (TTM) vs TTM 1 Yr. Ago -- 78.63 5.59
Sales - 5 Yr. Growth Rate -- 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 44.29 25.10 19.66
EPS (TTM) vs TTM 1 Yr. Ago -21.73 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate 112.65 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 1.83 5.30 2.97
LT Debt to Equity (MRQ) 0.00 22.82 12.22
Total Debt to Equity (MRQ) 0.00 24.47 16.52
Interest Coverage (TTM) -- -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -276.64 -- --
EBITD - 5 Yr. Avg -16,933.32 -572.68 10.86
Operating Margin (TTM) -277.56 -717.10 4.64
Operating Margin - 5 Yr. Avg. -16,804.50 -594.00 6.26
Pre-Tax Margin (TTM) -275.39 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -16,603.27 -597.35 6.60
Net Profit Margin (TTM) -275.39 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -16,603.27 -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 565,778 22,602,130 855,673,508
Net Income/Employee (TTM) -1,558,122 2,968,748 100,656,226
Receivable Turnover (TTM) -- 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.19 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.67 -1.05 10.98
Return on Assets - 5 Yr. Avg. -57.33 -0.57 12.37
Return on Investment (TTM) -85.01 1.66 14.43
Return on Investment - 5 Yr. Avg. -71.00 2.23 16.18
Return on Equity (TTM) -147.39 2.58 16.13
Return on Equity - 5 Yr. Avg. -686.83 3.13 17.47
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -56.90 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Akebia Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.85%
# of Holders: 180
Total Shares Held: 32,070,199
3 Mo. Net Change: 1,497,166
# New Positions: 34
# Closed Positions: 20
# Increased Positions: 105
# Reduced Positions: 63
# Net Buyers: 42
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.